{
  "functional_evidence_assessment": [
    {
      "Gene": "EGFR",
      "Protein_Change": {
        "ref": "L",
        "alt": "R",
        "position": "858"
      },
      "variant_string_id": "EGFR L858R"
    },
    {
      "Gene": "CFTR",
      "Protein_Change": {
        "ref": "H",
        "alt": "R",
        "position": "117"
      },
      "variant_string_id": "CFTR H117R"
    },
    {
      "Gene": "EGFR",
      "Protein_Change": {
        "ref": "L",
        "alt": "R",
        "position": "858"
      },
      "variant_string_id": "EGFR L858R"
    },
    {
      "Gene": "CFTR",
      "Protein_Change": {
        "ref": "H",
        "alt": "R",
        "position": "117"
      },
      "variant_string_id": "CFTR H117R"
    }
  ],
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The paper clearly defines the disease mechanism by mentioning that heterozygous mutations in PINK1 lead to loss of dopaminergic neurons.",
      "judgment": "Yes",
      "reasoning": "The paper specifies that mutations in PINK1 cause loss of dopamine neurons, which directly links to heterozygous mutations being pathogenic."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The assays used include cell viability assays under oxidative stress.",
      "judgment": "Yes",
      "reasoning": "Enzyme activity assays (e.g., cell survival tests) are standard methods to assess phenotypes resulting from mutations."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "The paper includes multiple replicates and controls, such as normal/positive wild-type proteins and replicative cell viability tests under oxidative stress.",
      "judgment": "Yes",
      "reasoning": "Basic controls (e.g., normal/positive PINK1) and replicative experimental designs are included, indicating a valid approach."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "The paper does not explicitly mention p-values or effect sizes, but multiple replicates (n=3) were used.",
      "judgment": "Yes",
      "reasoning": "Replicative results are mentioned and sufficient statistical rigor is present."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The evidence strongly supports that PINK1 mutations in the N-terminal, C-terminal, and kinase domains are pathogenic.\nHeterozygous mutations result in loss of dopaminergic neurons characteristic of familial and sporadic Parkinson disease."
}